Afya (NASDAQ:AFYA) Sees Unusually-High Trading Volume – Still a Buy?

Shares of Afya Limited (NASDAQ:AFYA) saw unusually-high trading volume on Thursday. Approximately 115,736 shares were traded during mid-day trading, a decline of 8% from the previous session’s volume of 126,422 shares. The stock last traded at $13.52 and had previously closed at $13.58.

Key Headlines Impacting Afya

Here are the key news stories impacting Afya this week:

• Positive Sentiment: Merger creates significant scale. Afya and Yduqs signed a binding agreement to combine their operations, creating a group with approximately 1.6 million students and R$9.4 billion in revenue. Afya shareholders are expected to own about 69.3% of the combined company. Afya Limited and Yduqs Enter Into Merger Agreement
• Positive Sentiment: Potential for stronger cash generation and synergies. Management commentary highlighted faster cash-flow generation and additional consolidation opportunities. Analysts cited potential synergies of as much as R$2.8 billion, while the transaction is also reported to include approximately R$750 million in dividends. JP Morgan merger scenarios
• Positive Sentiment: Analyst valuation remains above the market price. AFYA has a consensus price target of $17.75, implying substantial potential upside from recent trading levels. Afya consensus target price
• Neutral Sentiment: Listing and transaction structure remain important questions. Reports suggest the merger could affect AFYA’s Nasdaq listing, while the share-exchange structure, approvals and integration plans still need to be completed. These uncertainties may be limiting the immediate benefit of the announcement. Afya and Yduqs listing report
• Negative Sentiment: Short interest increased sharply. One report showed short interest rising 163.2% to 1.41 million shares as of September 15, equal to roughly 5.2 days of average volume. A separate report listed zero short interest, indicating inconsistent data; the increase should therefore be treated cautiously. Zacks Strong Sell list
• Negative Sentiment: Near-term sentiment is cautious. Zacks added AFYA to its No. 5, or “Strong Sell,” ranking, adding pressure while investors assess merger execution and the company’s future trading venue.

Wall Street Analysts Forecast Growth

Several research firms have commented on AFYA. Bradesco Corretora raised shares of Afya to an “outperform” rating and set a $17.00 price objective for the company in a report on Thursday. Weiss Ratings lowered Afya from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, July 31st. Bank of America reaffirmed a “neutral” rating on shares of Afya in a report on Thursday, June 11th. JPMorgan Chase & Co. decreased their target price on Afya from $21.50 to $21.00 and set a “neutral” rating on the stock in a research report on Monday, June 22nd. Finally, Zacks Research lowered Afya from a “hold” rating to a “strong sell” rating in a research note on Friday, August 21st. One investment analyst has rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Afya currently has a consensus rating of “Hold” and an average target price of $17.75.

Afya Trading Down 5.3%

The company has a quick ratio of 2.20, a current ratio of 2.20 and a debt-to-equity ratio of 0.39. The stock’s 50 day moving average is $14.00 and its 200-day moving average is $14.33. The company has a market cap of $1.22 billion, a PE ratio of 7.93, a P/E/G ratio of 1.54 and a beta of 0.35.

Afya (NASDAQ:AFYA) last issued its quarterly earnings data on Friday, August 14th. The company reported $0.43 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.03. Afya had a net margin of 20.55% and a return on equity of 17.58%. The business had revenue of $187.80 million during the quarter, compared to analysts’ expectations of $189.62 million. As a group, sell-side analysts anticipate that Afya Limited will post 1.86 EPS for the current year.

Insider Activity at Afya

In related news, VP Lélio de Souza, Jr. sold 36,204 shares of Afya stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $15.00, for a total value of $543,060.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 0.80% of the company’s stock.

Institutional Investors Weigh In On Afya

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in AFYA. Banco BTG Pactual S.A. purchased a new position in shares of Afya in the 4th quarter worth approximately $462,000. Engineers Gate Manager LP bought a new position in shares of Afya during the 2nd quarter valued at approximately $325,000. Finally, Public Employees Retirement System of Ohio purchased a new stake in Afya during the 2nd quarter valued at $67,000. 88.02% of the stock is currently owned by hedge funds and other institutional investors.

About Afya

Afya Limited is a Brazilian medical education and technology company that operates an integrated platform for physicians and medical students. The company provides education and professional development throughout the medical career cycle, from undergraduate training and residency preparation to continuing medical education and specialization programs.

Afya’s offerings include medical schools, preparatory courses, postgraduate and continuing education programs, digital learning tools, and clinical practice technologies.